Press release
BK virus infections Pipeline Insights 2024: Therapies, Clinical Trials, and Clinical Trials by DelveInsight | Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharma
"BK virus infections Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the BK virus infections Market.
The BK virus infections Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the BK virus infections Pipeline Report:
*
Companies across the globe are diligently working toward developing novel BK virus infections treatment therapies with a considerable amount of success over the years.
*
BK virus infections companies working in the treatment market are Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharmaceuticals, Vera Therapeutics, AlloVir, and others, are developing therapies for the BK virus infections treatment
*
Emerging BK virus infections therapies in the different phases of clinical trials are- BK virus antiviral therapy, AIC 468, AntiBKV antibody, Brincidofovir, MAU868, ALVR 105, and others are expected to have a significant impact on the BK virus infections market in the coming years.
*
In December 2023, AlloVir announced the discontinuation of its three Phase III posoleucel studies after separate, pre-planned DSMB futility analyses determined that the studies were unlikely to meet their primary endpoints. The company will now focus on preserving capital and reviewing strategic options.
*
In May 2023, Memo Therapeutics AG ("MTx"), a biotechnology firm specializing in the development of top-tier therapeutic antibodies, revealed today that the U.S. Food and Drug Administration ("FDA") has awarded Fast Track designation to AntiBKV, MTx's primary antibody therapeutic designed to address BK polyomavirus ("BKV") infection, frequently observed in individuals undergoing renal transplant. Having completed a phase I clinical study successfully, AntiBKV is now progressing to actively enroll patients for a crucial phase II/III clinical trial following FDA clearance.
BK virus infections Overview
BK virus (BKV) is a common virus that infects humans, usually during childhood. It belongs to the polyomavirus family and remains latent (inactive) in the body after initial infection. Most people do not experience any symptoms or health problems from BK virus infection.
Get a Free Sample PDF Report to know more about BK virus infections Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/bk-virus-bkv-infection-pipeline-insight [https://www.delveinsight.com/report-store/bk-virus-bkv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging BK virus infections Drugs Under Different Phases of Clinical Development Include:
*
BK virus antiviral therapy: Orthogon Therapeutics
*
AIC 468: AiCuris
*
AntiBKV antibody: Memo Therapeutics
*
Brincidofovir: SymBio Pharmaceuticals
*
MAU868: Vera Therapeutics
*
ALVR 105: AlloVir
BK virus infections Route of Administration
BK virus infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
*
Oral
*
Parenteral
*
Intravenous
*
Subcutaneous
*
Topical
BK virus infections Molecule Type
BK virus infections Products have been categorized under various Molecule types, such as
*
Recombinant fusion proteins
*
Small molecule
*
Monoclonal antibody
*
Peptide
*
Polymer
*
Gene therapy
BK virus infections Pipeline Therapeutics Assessment
*
BK virus infections Assessment by Product Type
*
BK virus infections By Stage and Product Type
*
BK virus infections Assessment by Route of Administration
*
BK virus infections By Stage and Route of Administration
*
BK virus infections Assessment by Molecule Type
*
BK virus infections by Stage and Molecule Type
DelveInsight's BK virus infections Report covers around 10+ products under different phases of clinical development like
*
Late-stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I)
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
*
Route of Administration
Further BK virus infections product details are provided in the report. Download the BK virus infections pipeline report to learn more about the emerging BK virus infections therapies [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key companies in the BK virus infections Therapeutics Market include:
Key companies developing therapies for BK virus infections are - AlloVir, Amplyx Pharmaceuticals, Memo therapeutics, Hybridize therapeutics, SLVaxiGenInc, and others.
BK virus infections Pipeline Analysis:
The BK virus infections pipeline report provides insights into
*
The report provides detailed insights about companies that are developing therapies for the treatment of BK virus infections with aggregate therapies developed by each company for the same.
*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for BK virus infections Treatment.
*
BK virus infections key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
BK virus infections Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the BK virus infections market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about BK virus infections drugs and therapies [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
BK virus infections Pipeline Market Drivers
*
Increase in the number of patients requiring kidney transplant worldwide, technological and medical advancements, guidelines supporting early detection and prompt diagnosis are some of the important factors that are fueling the BK virus infections Market.
BK virus infections Pipeline Market Barriers
*
However, due to the lack of effective treatment options against BK virus infection, biology of BKPyV is not completely understood. side effects associated with the current treatment options and other factors are creating obstacles in the BK virus infections Market growth.
Scope of BK virus infections Pipeline Drug Insight
*
Coverage: Global
*
Key BK virus infections Companies: Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharmaceuticals, Vera Therapeutics, AlloVir, and others
*
Key BK virus infections Therapies: BK virus antiviral therapy, AIC 468, AntiBKV antibody, Brincidofovir, MAU868, ALVR 105, and others
*
BK virus infections Therapeutic Assessment: BK virus infections current marketed and BK virus infections emerging therapies
*
BK virus infections Market Dynamics: BK virus infections market drivers and BK virus infections market barriers
Request for Sample PDF Report for BK virus infections Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/bk-virus-bkv-infection-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. BK virus infections Report Introduction
2. BK virus infections Executive Summary
3. BK virus infections Overview
4. BK virus infections- Analytical Perspective In-depth Commercial Assessment
5. BK virus infections Pipeline Therapeutics
6. BK virus infections Late Stage Products (Phase II/III)
7. BK virus infections Mid Stage Products (Phase II)
8. BK virus infections Early Stage Products (Phase I)
9. BK virus infections Preclinical Stage Products
10. BK virus infections Therapeutics Assessment
11. BK virus infections Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. BK virus infections Key Companies
14. BK virus infections Key Products
15. BK virus infections Unmet Needs
16 . BK virus infections Market Drivers and Barriers
17. BK virus infections Future Perspectives and Conclusion
18. BK virus infections Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bk-virus-infections-pipeline-insights-2024-therapies-clinical-trials-and-clinical-trials-by-delveinsight-orthogon-therapeutics-aicuris-memo-therapeutics-symbio-pharma]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: India
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BK virus infections Pipeline Insights 2024: Therapies, Clinical Trials, and Clinical Trials by DelveInsight | Orthogon Therapeutics, AiCuris, Memo Therapeutics, SymBio Pharma here
News-ID: 3577566 • Views: …
More Releases from ABNewswire
Understanding Magnetic Switches: Types, Working Principles, and Applications
A magnetic switch is a versatile electrical device that operates by responding to magnetic fields. From Hall Effect to reed switches, explore their functions, types, and diverse applications.
What is a Magnetic Switch?
A magnetic switch is an electrical device that operates by responding to the presence of a magnetic field. It functions by closing or opening its contacts based on the strength of the magnetic field. Specifically, the switch remains closed…
Innovating embedded downlight technology: Leading the global trend of intelligen …
The strong rise of China's manufacturing industry has profoundly reshaped the technological landscape and development trajectory of embedded downlights. With its unparalleled industrial chain advantages, continuous technological innovation, and significant cost-effectiveness, Chinese enterprises have risen from participants in the global lighting industry to undisputed leaders. This transformation goes far beyond the huge production scale; it lies in the thorough innovation of the core technical content and application boundaries of embedded…
North China Electric Power University Foreign Aid Training Program Visits Yiyuan …
On July 23, 2025, the Electrical Industry Training Program of North China Electric Power University's Foreign Aid Project visited Yiyuan Technology for an exchange visit. The purpose was to gain in-depth insights into the company's innovations in renewable energy technology promotion and application [https://www.yiyen.com/about/], and to build bridges connecting university-enterprise cooperation with foreign aid initiatives.
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-1.jpg
Image: https://ecdn6.globalso.com/upload/p/1108/image_other/2025-07/scene-3.jpg
Upon arrival, the delegation received a warm welcome from company leadership and the reception…
Pure Sine Wave Low Frequency Inverter Charger
Pure sine wave low frequency inverter [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] is widely used and suitable for a variety of scenarios. In terms of home backup power, it can provide reliable power during power outages, ensuring that essential appliances such as refrigerators, air conditioners and medical equipment continue to operate . For solar power generation systems, Inverter charger [https://www.yiypower.com/ap-mini-600w-1500w-120v-low-frequency-pure-sine-wave-inverter-charger-product/] can converter DC Power from Battery, which charged by solar panels, into clean alternating current…
More Releases for Therapeutic
Exosome Therapeutic Market : Detailed Overview
Introduction:
The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,…
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),…
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028.
Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market.
Browse 147 Market Data Tables and 115…
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
